Smart for Life (SMFL) Competitors $0.0037 +0.00 (+37.04%) As of 10/17/2025 01:25 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SMFL vs. VRPX, SCPS, VAXX, TRVN, ARDS, NAVB, GNCAQ, GNCA, STAB, and EVLOShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Virpax Pharmaceuticals (VRPX), Scopus BioPharma (SCPS), Vaxxinity (VAXX), Trevena (TRVN), Aridis Pharmaceuticals (ARDS), Navidea Biopharmaceuticals (NAVB), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Statera Biopharma (STAB), and Evelo Biosciences (EVLO). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Its Competitors Virpax Pharmaceuticals Scopus BioPharma Vaxxinity Trevena Aridis Pharmaceuticals Navidea Biopharmaceuticals Genocea Biosciences Genocea Biosciences Statera Biopharma Evelo Biosciences Smart for Life (NASDAQ:SMFL) and Virpax Pharmaceuticals (NASDAQ:VRPX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership. Do institutionals and insiders hold more shares of SMFL or VRPX? 28.4% of Smart for Life shares are held by institutional investors. Comparatively, 32.2% of Virpax Pharmaceuticals shares are held by institutional investors. 31.7% of Smart for Life shares are held by company insiders. Comparatively, 3.7% of Virpax Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger earnings and valuation, SMFL or VRPX? Virpax Pharmaceuticals has lower revenue, but higher earnings than Smart for Life. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.00-$22.68MN/AN/AVirpax PharmaceuticalsN/AN/A-$15.19MN/AN/A Is SMFL or VRPX more profitable? Smart for Life's return on equity of 0.00% beat Virpax Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Virpax Pharmaceuticals N/A -1,554.34%-338.29% Does the media refer more to SMFL or VRPX? In the previous week, Smart for Life's average media sentiment score of 0.00 equaled Virpax Pharmaceuticals'average media sentiment score. Company Overall Sentiment Smart for Life Neutral Virpax Pharmaceuticals Neutral Which has more volatility and risk, SMFL or VRPX? Smart for Life has a beta of 16.69, suggesting that its stock price is 1,569% more volatile than the S&P 500. Comparatively, Virpax Pharmaceuticals has a beta of 1.96, suggesting that its stock price is 96% more volatile than the S&P 500. SummarySmart for Life beats Virpax Pharmaceuticals on 5 of the 7 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SMFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$26K$3.88B$6.14B$10.56BDividend YieldN/AN/A5.72%4.83%P/E RatioN/A10.0385.7027.05Price / Sales0.0078.10612.92132.35Price / CashN/A7.2425.8230.35Price / Book0.001.4312.226.58Net Income-$22.68M$19.57M$3.33B$276.84M7 Day PerformanceN/A-13.54%1.17%1.93%1 Month PerformanceN/A-5.52%6.85%2.19%1 Year PerformanceN/A-4.55%58.93%34.62% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.00+37.0%N/A-87.7%$26K$11.11M0.00110Gap DownVRPXVirpax Pharmaceuticals0.2135 of 5 stars$0.01-47.6%N/A-99.9%$14KN/A0.007SCPSScopus BioPharmaN/A$0.00-70.0%N/AN/A$13KN/A0.009VAXXVaxxinityN/A$0.00flatN/A-50.0%$13KN/A0.0090Gap UpTRVNTrevena1.4481 of 5 stars$0.01flat$5.00+41,566.7%-99.4%$12K$443K0.0040ARDSAridis PharmaceuticalsN/A$0.00flatN/AN/A$11KN/A0.0030Gap DownNAVBNavidea BiopharmaceuticalsN/AN/AN/AN/A$10K$8.13K0.0010High Trading VolumeGNCAQGenocea BiosciencesN/AN/AN/AN/A$6KN/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6K$1.91M0.0070STABStatera BiopharmaN/A$0.00flatN/AN/A$5KN/A0.0020High Trading VolumeEVLOEvelo BiosciencesN/A$0.00flatN/A-33.3%$4KN/A0.00120News CoverageOptions Volume Related Companies and Tools Related Companies Virpax Pharmaceuticals Competitors Scopus BioPharma Competitors Vaxxinity Competitors Trevena Competitors Aridis Pharmaceuticals Competitors Navidea Biopharmaceuticals Competitors Genocea Biosciences Competitors Genocea Biosciences Competitors Statera Biopharma Competitors Evelo Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMFL) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.